-
Mashup Score: 3
The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke’s Mid America Heart Institute, shared details on the tracer in a new interview.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
In his first president’s message to American Society of Nuclear Cardiology (ASNC), 2023 President Mouaz H. Al-Mallah, MD, MSc, FASNC, called for the cardiac imaging subspecialty to up its game with new technology [1]. “Nuclear cardiology imaging remains at the center stage in the era of multimodality testing,” Al-Mallah said in his first President’s Message to ASNC members this past week….
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Flurpiridaz data shows promise to expand and enhance cardiac PET - 2 year(s) ago
The biggest news from the American Society of Nuclear Cardiology (ASNC) 2022 meeting was positive late-breaking data on the phase 3 Aurora trial for the flurpiridaz (F-18) positron emission tomography (PET) radiotracer agent. Numerous nuclear cardiology experts have predicted the radiopharmaceutical might significantly accelerate PET adoption in nuclear cardiology with its 106 minute half life…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to answer cardiac imagers’ questions about SPECT/CT and PET/CT imaging with attenuation correction, localization of radiotracer uptake and coronary artery calcium scoring (CACS). In a new multisociety guideline published today in the Journal of Nuclear Cardiology, the organizations…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
August 10, 2022 — On July 27, ASNC joined a coalition of more than 100 medical societies urging Congress to pass legislation that provides at least a 4.5 percent conversion factor adjustment and waives a statutory PAYGO requirement that will otherwise result in a 4 percent sequestration next year on top of the existing 2 percent sequestration. The letter specifies that any legislation should…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0CMS Releases 2023 Medicare Physician Fee Schedule Proposed Rule - 2 year(s) ago
July 19, 2022 — On July 7, the Centers for Medicare & Medicaid Services (CMS) released the 2023 Medicare Physician Fee Schedule (PFS) proposed rule. In the days ahead the American Society of Nuclear Cardiology’s (ASNC) advocacy team will analyze the proposed rule and report to you on specifics that may impact your practice as well as any actions ASNC will take. CMS also posted a notice about the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson (Lexiscan) and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting last week. Many cardiologists prefer to use…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Cardiologist and ASNC president diagnoses the heart of the galaxy based on black hole imaging - 2 year(s) ago
The first image of the black hole at the center of our Milky Way galaxy released May 12 amazed the scientific community. However, cardiologists were left with questions about the true health of the galaxy. The immediate takeaway for most cardiology imagers and radiologists when they saw the historic black hole image was the amazing similarity to…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Cardiovascular Imaging Organizations Denounce Test Substitution by Insurance Companies - 3 year(s) ago
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by insurers’ test substitution policies, according to a statement published online in the Journal of the American College of Cardiology.[1] The statement summarizes the proceedings of a recent summit convened by the American Society of Nuclear Cardiology (ASNC), where six leading…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
Video - Flurpiridaz is poised to make a major impact on nuclear cardiology. Tim Bateman, MD, explains details on the AURORA trial. #ASNC @MyASNC #PET #Flurpiridaz #Nuclearimaging https://t.co/9m59nmyrWU